Does	O
genistein	B:C0061202
lower	O
plasma	B:C0022885
lipids	I:C0022885
and	O
homocysteine	B:C1278166
levels	I:C1278166
in	O
postmenopausal	B:C0206159
women	B:C0043210
?	O

A	O
meta-analysis	B:C0920317
.	O

To	O
perform	O
a	O
meta-	B:C0920317
analysis	I:C0920317
examining	B:C0332128
the	O
effects	O
of	O
genistein	B:C0061202
on	O
homocysteine	O
and	O
lipid	B:C0022885
levels	I:C0022885
in	O
postmenopausal	B:C0206159
women	B:C0043210
.	O

We	O
systematically	O
searched	O
the	O
PubMed	B:C1138432
,	O
MEDLINE	B:C0025141
,	O
and	O
Cochrane	B:C0242356
Library	I:C0242356
databases	I:C0242356
and	O
the	O
ClinicalTrials.gov	B:C4086204
website	I:C4086204
for	O
studies	B:C2603343
.	O

We	O
performed	O
a	O
meta	B:C0920317
-	I:C0920317
analysis	I:C0920317
using	O
weighted	O
mean	O
differences	O
(	O
WMD	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
in	O
a	O
random	O
-	O
effects	O
model	O
.	O

We	O
assessed	O
between	O
-	O
study	B:C2603343
heterogeneity	O
using	O
the	O
Cochran	O
's	O
Q	O
and	O
I	O
(	O
2	O
)	O
statistics	O
.	O

Eight	O
randomized	B:C0206035
,	I:C0206035
controlled	I:C0206035
trials	I:C0206035
with	O
a	O
total	O
of	O
476	O
subjects	O
were	O
included	O
in	O
the	O
meta-	B:C0920317
analysis	I:C0920317
.	O

Compared	O
with	O
placebos	B:C0032042
,	O
genistein	B:C0061202
was	O
effective	O
in	O
reducing	O
plasma	B:C0032105
levels	O
of	O
homocysteine	B:C0019878
(	O
WMD	O
,	O
-	O
0.58	O
Î¼mol	O
/l	O
;	O
p	O
=	O
0.001	O
)	O
,	O
and	O
increasing	O
high	B:C0023822
density	I:C0023822
lipoprotein	I:C0023822
(	I:C0023822
HDL	I:C0023822
)	I:C0023822
cholesterol	I:C0023822
levels	O
(	O
WMD	O
,	O
4.9	O
mg	O
/dl	O
;	O
p	O
=	O
0.0002	O
)	O
.	O

Subgroup	B:C0242481
analyses	I:C0242481
revealed	O
that	O
genistein	B:C0061202
significantly	O
decreased	O
the	O
levels	O
of	O
low	B:C0023824
density	I:C0023824
lipoprotein	I:C0023824
(	I:C0023824
LDL	I:C0023824
)	I:C0023824
cholesterol	I:C0023824
(	O
WMD	O
,	O
-	O
16.90	O
mg/dl	O
;	O
p	O
=	O
0.01	O
)	O
,	O
total	B:C0543421
cholesterol	I:C0543421
(	O
WMD	O
,	O
-	O
15.83	O
mg/dl	O
;	O
p	O
=	O
0.008	O
)	O
,	O
and	O
triglycerides	B:C0041004
(	O
WMD	O
,	O
-	O
46.58	O
mg/dl	O
;	O
p	O
=	O
0.03	O
)	O
in	O
postmenopausal	B:C0206159
women	B:C0043210
with	O
metabolic	B:C0025517
syndrome	I:C0025517
,	O
but	O
had	O
no	O
significant	O
effects	O
in	O
those	O
with	O
no	B:C0025517
metabolic	I:C0025517
syndrome	I:C0025517
.	O

Our	O
meta	B:C0920317
-	I:C0920317
analysis	I:C0920317
demonstrates	O
that	O
genistein	B:C0061202
significantly	O
reduces	O
homocysteine	B:C1278166
levels	I:C1278166
and	O
increases	O
HDL	B:C1278148
cholesterol	I:C1278148
levels	I:C1278148
in	O
postmenopausal	B:C0206159
women	B:C0043210
.	O

Genistein	B:C0061202
also	O
significantly	O
decreases	O
LDL	B:C1278149
cholesterol	I:C1278149
,	O
total	B:C1272107
cholesterol	I:C1272107
and	O
triglyceride	B:C0583329
levels	I:C0583329
in	O
postmenopausal	B:C0206159
women	B:C0043210
with	O
metabolic	B:C0025517
syndrome	I:C0025517
.	O

